+987.9%
MRNA vs ENB
+9.4%
+978.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.3% | +13.4% | +12.5% |
| 7D | +20.6% | +0.5% | +20.2% | +21.7% |
| 30D | +27.1% | +6.0% | +21.2% | +42.7% |
| 3M | +353.4% | -7.4% | +360.8% | +327.5% |
| 6M | +446.3% | -8.5% | +454.7% | +413.0% |
| YTD | +776.2% | +6.1% | +770.1% | +724.9% |
| 1Y | +987.9% | +9.4% | +978.5% | +905.2% |
| All | +987.9% | +9.4% | +978.5% | +905.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling